These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-grade endometrial stromal sarcoma following tamoxifen treatment. Engin H. Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038 [No Abstract] [Full Text] [Related]
3. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer. Sesti F, Patrizi L, Ermini B, Palmieri G, Orlandi A, Piccione E. Gynecol Obstet Invest; 2005 Jan; 60(2):117-20. PubMed ID: 15920338 [Abstract] [Full Text] [Related]
4. Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer. Boardman CH, Webb MJ, Jefferies JA. Gynecol Oncol; 2000 Oct; 79(1):120-3. PubMed ID: 11006043 [Abstract] [Full Text] [Related]
5. Endometrial stromal sarcoma with sex cord-like differentiation associated with tamoxifen therapy. Pang LC. South Med J; 1998 Jun; 91(6):592-4. PubMed ID: 9634127 [Abstract] [Full Text] [Related]
9. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor. Leiser AL, Hamid AM, Blanchard R. Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205 [Abstract] [Full Text] [Related]
10. Role of prolonged stimulation of tamoxifen therapy in the etiology of endometrial sarcomas. Altaras MM, Aviram R, Cohen I, Cordoba M, Yarkoni S, Beyth Y. Gynecol Oncol; 1993 May; 49(2):255-8. PubMed ID: 8504996 [Abstract] [Full Text] [Related]
11. Hormonal therapy of endometrial stromal sarcoma. Reich O, Regauer S. Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798 [Abstract] [Full Text] [Related]
12. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients. Robinson DC, Bloss JD, Schiano MA. Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470 [Abstract] [Full Text] [Related]
13. Iatrogenic endometrial megapolyps in women with breast carcinoma. Berezowsky J, Chalvardjian A, Murray D. Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466 [Abstract] [Full Text] [Related]
14. Low-grade endometrial stromal sarcoma developing in a postmenopausal woman under toremifene treatment for breast cancer. Kashiyama T, Oda K, Kawana K, Arimoto T, Kanetaka Y, Takazawa Y, Maeda D, Nakagawa S, Yano T, Kozuma S. J Obstet Gynaecol Res; 2013 Jan; 39(1):424-9. PubMed ID: 22690656 [Abstract] [Full Text] [Related]
15. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group. J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574 [Abstract] [Full Text] [Related]
16. Endometrial stromal sarcoma development after hysterectomy and tamoxifen therapy. Christie DB, Day JD, Moore AB, Chapman JR, Nakayama DK, Conforti AM. Am Surg; 2008 Aug 02; 74(8):726-8. PubMed ID: 18705574 [Abstract] [Full Text] [Related]
17. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer. Hubalek M, Ramoni A, Mueller-Holzner E, Marth C. Gynecol Oncol; 2004 Oct 02; 95(1):264-6. PubMed ID: 15385144 [Abstract] [Full Text] [Related]
18. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report. Sinawat S, Chiyabutra T, Kleabkaew P. J Med Assoc Thai; 2001 Jul 02; 84(7):1033-6. PubMed ID: 11759963 [Abstract] [Full Text] [Related]